The development of laser and light therapy for skin resurfacing has revolutionized the treatment of photodamage, wrinkles, scars, and a variety of pigmented lesions. The earliest lasers used for this purpose were ablative and included carbon dioxide (CO 2 ) and erbium: yttrium aluminum garnet (Er:YAG) devices. Treatment with these ablative lasers results in coagulation and vaporization of the entire epidermal unit with the goal of improving the quality of treated skin. Downtime is in the range of 5 to 14 days, and over this period of time patients can experience edema, oozing, and discomfort. Erythema can last for months to years and dyspigmentation, including depigmentation, can appear at any time after treatment-including years later. These complications are of particular concern for patients of higher Fitzpatrick skin types, and limit the use of these lasers to Fitzpatrick types I through III. Infection and scarring can occur as well due to prolonged compromise of the epidermal barrier unit. Results are dramatic for reversal of photoaging, but the side-effect profile is a deterrent for some patients and physicians and has limited the use of fully ablative laser resurfacing. 1,2,3 Nonablative technologies were developed to allow for faster postprocedure skin recovery, targeting the deep dermis to remodel collagen. Although these lasers have the benefit of shorter downtime, more sessions are required to achieve results similar to the ablative lasers, often requiring five or six monthly treatments. These devices are also typically paired with a cooling tip that allows for cooling of the epidermis and selective treatment to the dermis. The damage induced by nonablative devices is by definition "not ablative" and does not result in disruption of the epidermis or vaporization of tissue. Characteristic histology includes coagulation of dermal components. The term nonablative is broad in nature, and can include any device that does not cause ablation. However, for true practical purposes, and for this chapter, the nonablative devices are those that are moderately absorbed by water with wavelengths ranging from 1,064 to 2,000 nm. Other devices, which deliver nonspecific thermal energy and are by definition nonablative such as radiofrequency and ultrasound technologies, are not discussed here.
Nonablative Nonfractionated LasersThe 1,320-nm neodymium:yttrium aluminum garnet (Nd:YAG) laser (CoolTouch, ICN Pharmaceuticals, Costa Mesa, California) was the first exclusively nonablative laser developed. Energy penetration occurs to a depth of 1,600 µm, a potentially effective treatment depth. Safety was optimal, yet studies showed only minimal clinical improvement in rhytids and photoaging. 4,5,6 The Smoothbeam laser (Candela Corp., Wayland, Massachusetts) emits coherent light at 1,450 nm. This device also uses water as the chromophore and results in thermal injury to the dermis and dermal components. The epidermis is protected via dynamic cryogen cooling. In 2003, Tanzi et al reported a mild to moderate clinical improvement ...